鱼跃医疗收盘上涨1.04%，滚动市盈率20.26倍，总市值358.89亿元

Core Insights - Yuyue Medical's stock closed at 35.8 yuan, with a PE ratio of 20.26, marking a new low in 26 days, and a total market capitalization of 35.889 billion yuan [1] - The average PE ratio in the medical device industry is 49.84, with a median of 36.65, placing Yuyue Medical at the 47th position [1][2] - As of April 18, 2025, Yuyue Medical has 40,000 shareholders, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Company Overview - Yuyue Medical specializes in the research, manufacturing, and sales of medical devices, focusing on areas such as respiratory oxygen, diabetes care, infection control solutions, home electronic testing, in vitro diagnostics, emergency and clinical rehabilitation equipment [1] - The company owns several major brands, including "Yuyue," "Jiefuro," "Hua Tuo," "Jin Zhong," "An Er Iodine," "Primedic," and "Liuliu Vision," with significant brand value and advantages due to product performance and effective brand communication [1] Financial Performance - In Q1 2025, Yuyue Medical reported revenue of 2.436 billion yuan, a year-on-year increase of 9.17%, while net profit was 625 million yuan, reflecting a year-on-year decrease of 5.26%, with a gross profit margin of 50.30% [2] - The company's PE (TTM) is 20.26, with a static PE of 19.88 and a price-to-book ratio of 2.74 [2]